4
Changes in Ownership
Theriva Biologics, Inc. Filed Acc 0000890163-07-000253
Chief Executive Officer bought 227,000 shares at an average $1.96 ($445,580)
From the SEC's structured data for this filing
Trades in this filing
KANZER STEVE H · Chief Executive Officer
Table I: Non-derivative
17 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2007-04-16 | Purchase : show line 1 in the form | +2,000 | $1.82 | $3,640 | 197,238 | D |
| 2007-04-16 | Purchase : show line 2 in the form | +2,000 | $1.83 | $3,660 | 199,238 | D |
| 2007-04-16 | Purchase : show line 3 in the form | +41,000 | $1.84 | $75,440 | 240,238 | D |
| 2007-04-16 | Purchase : show line 4 in the form | +2,500 | $1.85 | $4,625 | 242,738 | D |
| 2007-04-16 | Purchase : show line 5 in the form | +10,000 | $1.86 | $18,600 | 252,738 | D |
| 2007-04-16 | Purchase : show line 6 in the form | +2,500 | $1.87 | $4,675 | 255,238 | D |
| 2007-04-16 | Purchase : show line 7 in the form | +32,500 | $1.95 | $63,375 | 287,738 | D |
| 2007-04-16 | Purchase : show line 8 in the form | +10,000 | $1.99 | $19,900 | 297,738 | D |
| Open-market purchases · 227,000 sh · avg $1.96 · $445,580 | ||||||
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2006-01-27 | Grant or award : show line 18 in the form Warrants | +3,618,735 | 3,618,735 | I |
| 2007-01-07 | Grant or award : show line 19 in the form Warrants | +22,953 | 22,953 | D |
Loading xslF345X02/s11-7312_ex.xml…